Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Hypercalcemia Treatment Industry By 2029?

Over the past few years, the hypercalcemia treatment market has experienced a swift expansion. The market which was valued at $16.44 billion in 2024, is projected to reach $18.29 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.2%. The substantial growth observed during this historic period is due to factors such as increased awareness about hypercalcemia, a surge in the elderly population, higher instances of cancer, improved disease cognizance, and an increase in the occurrence of parathyroid disorders.

In the forthcoming years, the hypercalcemia treatment market is projected to experience swift expansion, reaching a value of $28.08 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 11.3%. This accelerated growth during the predicted timeframe can be associated with a surge in instances of chronic kidney disease, an increasing count of hypertension patients, heightened spending on the innovation of new medications, amplified awareness and empowerment among patients, and government interventions. The forthcoming era is anticipated to witness a rise in sophisticated diagnostic apparatus and methodologies, progression in treatments, introduction of innovative medicinal drugs, and alliances formed between healthcare institutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21206&type=smp

Which Industry Forces Are Driving The Hypercalcemia Treatment Market Forward?

The increasing occurrence of parathyroid disorders is anticipated to stimulate the expansion of the hypercalcemia treatment market. Parathyroid disorders are conditions that impact the parathyroid glands, which control body calcium levels via the parathyroid hormone’s (PTH) production. The escalating occurrence of these disorders is catalyzed by factors such as an aging population, heightened awareness, advanced diagnostic abilities, and the growing prevalence of conditions like primary hyperparathyroidism and chronic kidney disease. Hypercalcemia treatment plays a vital role in handling parathyroid disorders by managing increased calcium levels to avert problems like kidney stones and bone loss, eventually enhancing metabolic equilibrium. For instance, the National Institute of Health (NIH), a US government agency, stated in February 2024 that in the United States, the prevalence rate for hypoparathyroidism is projected to be 6.4 to 37 per 100,000 person-years, with 75% of the cases resulting from complications arising from thyroidectomy or head and neck surgeries. Consequently, the surging occurrence of parathyroid disorders fuels the expansion of the hypercalcemia treatment market.

What Is The Segment Breakdown Of The Hypercalcemia Treatment Market?

The hypercalcemia treatmentmarket covered in this report is segmented –

1) By Drug Type: Bisphosphonates; Calcitonin; Glucocorticoids; Denosumab; Calcimimetics; Other Drug Types

2) By Indication: Primary Hyperthyroidism; Hypercalcemia Of Malignancy; Other Indications

3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies

4) By End-Users: Hospitals; Clinics

Subsegments:

1) By Bisphosphonates: Zoledronic Acid; Pamidronate; Alendronate

2) By Calcitonin: Salmon Calcitonin; Synthetic Calcitonin

3) By Glucocorticoids: Prednisone; Dexamethasone; Hydrocortisone

4) By Denosumab: Denosumab (Monotherapy); Denosumab Combination Therapy

5) By Calcimimetics: Cinacalcet; Etelcalcetide

6) By Other Drug Types: Gallium Nitrate; Mithramycin

What New Opportunities Are Emerging From Trends In The Hypercalcemia Treatment Market?

Major companies in the hypercalcemia treatment market are committed to creating innovative therapies such as phosphate binders to better control calcium and phosphate levels, leading to improved patient outcomes. Phosphate binders are drugs that attach to phosphate in the digestive system, blocking its absorption and are commonly prescribed to patients with kidney disease or hypercalcemia. For example, in May 2024, Strides Pharma Science Limited, an India-based pharmaceutical manufacturer, received FDA approval for its Sevelamer Carbonate Tablets (800 mg). These tablets are used to manage hyperphosphatemia in patients with chronic kidney disease, by binding dietary phosphate to prevent it from entering the bloodstream. This helps support bone health and reduces the cardiovascular risks that come with high phosphate levels.

Which Companies Are Contributing Significantly To The Hypercalcemia Treatment Market Growth?

Major companies operating in the hypercalcemia treatment market are Pfizer Inc., Roche Holding AG, AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Merck KGaA, Fresenius Medical Care AG & Co. KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen SA, Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals plc, Endo International plc, OPKO Health Inc., Ferring Pharmaceuticals A/S, Rockwell Medical Inc., Strides Pharma Science Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hypercalcemia-treatment-global-market-report

Which Region Is Leading Innovation In The Hypercalcemia Treatment Market?

North America was the largest region in the hypercalcemia treatment market in 2024. The regions covered in the hypercalcemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21206&type=smp

Browse Through More Reports Similar to the Global Hypercalcemia Treatment Market 2025, By The Business Research Company

Bleeding Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Autoimmune Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Infertility Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model